Hormetic Stress Biohacking Type 1 Diabetes CGM

Image
Photo: Unsplash.com Medical Disclaimer : The content on this blog is purely for informational purposes only. For medical advice, diagnosis and treatment, consult your doctor. The ultimate goal for anyone living with Type 1 Diabetes (T1D) is stability. You want fewer spikes, fewer crashes, and more time spent in your target blood sugar range. Read more on blood sugar spike . For years, standard medical advice focused purely on matching insulin doses to carbohydrate intake. While this foundational math is necessary, it often leaves people riding a frustrating blood sugar roller coaster. Today, a new wave of tech-savvy individuals is looking beyond the traditional playbook. They are combining the principles of biohacking, the physiological benefits of hormetic stress, and the real-time data of Continuous Glucose Monitors (CGMs) to transform how they manage their health. This approach does not replace insulin. Instead, it aims to make the body more resilient, predictable, and res...

Opioid Addiction Treatment Options

FDA Commissioner, Marty Makary


The U.S. Food and Drug Administration (FDA) has taken steps to address the opioid crisis by exploring new standards for in-home opioid disposal products

The agency has issued a Request for Information (RFI) seeking public comment on potential requirements for opioid sponsors to provide in-home disposal systems through pharmacies and other dispensers.

Currently, the FDA recommends disposing of unused opioids through drug take-back locations or mailing them back using prepaid envelopes provided by pharmacies. For certain high-risk medications, the agency suggests flushing them down the toilet, which has been shown to pose a negligible eco-toxicological risk, according to a 2017 study in the Science of Total Environment.

The FDA is considering requiring opioid sponsors to make in-home disposal systems available, which could include products that render opioids unusable or non-retrievable. The agency is seeking input on appropriate criteria for these systems, including their effectiveness, safety, and usability.

The FDA's effort aligns with the SUPPORT for Patients and Communities Reauthorization Act of 2025 and President Trump's Great American Recovery initiative. The goal is to reduce the risks associated with unused opioids in American homes, which can contribute to misuse and addiction.

The public can submit comments on the RFI until April 6, 2026. The FDA will review the feedback and consider implementing new standards for in-home opioid disposal products.

The opioid crisis is a complex public health issue involving widespread misuse and overdose of opioid medications, leading to addiction, deaths, and societal impacts. Key factors include:

- Overprescription: Widespread prescription of opioids for pain management contributed to initial exposure and addiction.

- Illicit Opioids: Fentanyl and other synthetic opioids have increased potency and risk of overdose.

- Addiction and Overdose: Opioid use can lead to dependence, overdose, and death.


Comments

Popular posts from this blog

The Impressive Health Benefits of Pumpkin Seeds

The Grave Consequences of Attacking Health Sites in Iran

Why Gastric Ulcer Patients Should Avoid Tomatoes and Tomato-Based Products